RNS Number : 7248U
Deepverge PLC
07 April 2021
 

AIM share code: DVRG

7 April 2021

DeepVerge PLC

("DeepVerge" or "Company")

 

 

Exercise of Options

 

DeepVerge announces that it has received notification from UK EMI employee share option holders to exercise 18,102 shares in the issued share capital of DeepVerge ("the Option Shares"). The consideration for the exercise of the Option Shares at nominal value of 0.1p amounts, in aggregate, to a cash value of £18.10.

 

Application will be made for the Option Shares to be admitted to trading on AIM ("Admission"). Admission is expected to be on or about 13 April 2021.

 

Total voting rights

 

The Company's total issued capital, after the issue of the Option Shares, will be 173,195,661 ordinary shares. As the Company does not hold any shares in Treasury, this figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company following Admission.

 

 

Contacts

 

DeepVerge plc

Gerard Brandon, CEO

+44 (0) 7340 055 648




SPARK Advisory Partners Limited

(Nominated Adviser)

Neil Baldwin/Andrew Emmott

+44 (0) 113 370 8974




Turner Pope Investments (TPI) Limited (Broker)

Andy Thacker/Zoe Alexander

+44 (0) 20 3657 0050

 

 

About DeepVerge plc (www.deepverge.com)

DeepVerge is an environmental and life science group of companies that develops and applies AI and IoT technology to analytical instruments for the analysis and identification of bacteria, virus and toxins. Utilising artificial intelligent data analytics to scientifically prove the impact of skincare product claims on skin microbiome for most of the top 20 global cosmetic company clients and remotely detect and identify in real-time, dangerous pathogens in wastewater treatment plants, drinking water, rivers, lakes and reservoirs.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEBSGDSGSGDGBR